Science that is transforming lives and enabling the future

Four Important Things to Validate in Your Freeze/Thaw Workflow

All Posts

Four Important Things to Validate in Your Freeze/Thaw Workflow

The impact of the freeze/thaw process on workflows requires it be treated as a unit operation of its own.

Based on current trends, 30 of the top 50 global biopharma products will require cold chain handling resulting from more complex therapeutics, scale-up of biosimilars, expanding distribution range, regulatory increases, and pandemic-targeted therapies. Ensuring your freeze/thaw workflow is validated along the way is critical in the safe delivery and distribution of sensitive products, as well as time, expense, and patient considerations. Protect, fill, freeze, store, ship, thaw, and drain; there are many opportunities for failures to happen along the process workflow.
A cracked bag can cause contamination. Warm temperatures during shipping could compromise drug proteins. Getting it right during validation ensures that the product can be delivered to patients the way it was intended.

Ensuring the safety, purity, and efficacy of biopharma products continues to be at
the forefront of drug manufacturers’ development and delivery process. Complex therapeutics coupled with multifaceted global logistics require validation throughout the drug manufacturing journey. For long-term product stability and decoupled manufacturing flexibility, freeze/thaw workflows are employed. Here, not only is storage temperature important, but container integrity and rates of freezing and thawing can compromise drug proteins. Customers need a controlled, consistent, and scalable cold chain workflow where product materials are stored, handled, or transported in a manner that mitigates risk for breakage, contamination, and expensive product loss.

Four important considerations to validate in your freeze/thaw workflow. How do you validate these? What are the pitfalls?

1. Primary Container

  • Understanding the impact from all fluid contact surfaces on the biological product. Characterizing the product’s sensitivities (pH, UV light, adsorption, etc.) and validating primary contact materials that ensure product purity and stability during storage and transport.  

2. Freeze/Thaw Process

  • Developing and validating a repeatable freeze and thaw process that enables maximum product recovery. Utilizing a cooling and warming rate that reduces cryoconcentration, aggregation, denaturation, or other undesirable changes to the product’s critical quality attributes.

3. Scalable Freeze/Thaw Equipment

  • The freeze/thaw process should utilize scalable equipment that can be validated at the initial lab/feasibility scale all the way up to production/commercial scale. Identification and sourcing of new equipment
    or utilization of existing infrastructure will guide the validation approach.

4. Shipping/Distribution Lane

  • Shipping containers and related packaging materials must be validated in both thermal and mechanical transportation environments that best represent the expected distribution lane. This reduces the risk of container breakage or contamination as well as temperature excursions that compromise product integrity.

As a trusted partner provider of single-use solutions for bulk freeze/thaw storage
and transport, we understand unique customer needs. By delivering customized solutions backed by a global infrastructure, customers receive beneficial outcomes.

Our world-class Life Sciences Technology Center is dedicated to offering customers access to experts who, with their deep knowledge of testing, equipment, and containment, will guide you through freeze/thaw process optimization strategies.

Learn more about how we can help.

Related Posts

How Does Quality by Design Affect Bulk Drug Cold Chain Manufacturing?

As a world-class supplier of advanced materials and process solutions for the semiconductor space, we understand the complexity and challenges of quality by design with respect to bulk drug cold chain manufacturing. Costly failures can be devastating and, in many cases, can be avoided by partnering with the correct single-use solutions provider to help optimize critical processes. When looking for solutions to protect your therapeutics during bulk drug cold chain, keep the following in mind:

Discussion of Freeze/Thaw Workflows

Meet Regulatory Requirements to Ensure Patient Safety Developing and validating a robust freeze/thaw process while meeting regulatory guidelines is a multifaceted challenge. The demand for cold chain processes and operations for biopharma products is increasing due to scaling of complex therapeutics, a challenging global supply chain, and growing shipping complexities. Ensuring compliance throughout the product journey is integral to mitigating risk for product loss and contamination.

Benchmarks Bridge the Semiconductor Yield and Reliability Performance Gap in the Automotive Domain

A major difference exists as more features from our smartphones are integrated, replicated, and expanded in our cars - reliability expectations. A smartphone is designed to work effectively for 3-5 years while cars expect 10-15 years with standard maintenance. Failure in our cars can create dangerous situations for drivers, passengers, and others on the roadway. Designing and manufacturing our cars to ensure the functional safety along with the performance expectations of our new digital transportation systems is challenging manufacturing models for carmakers.